These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 21122697

  • 1. An evaluation of alanine transaminase and creatine kinase elevations with the use of ezetimibe in an ambulatory care setting.
    McGinnis B, Schimmer J, Hutka K.
    J Clin Lipidol; 2010; 4(6):501-7. PubMed ID: 21122697
    [Abstract] [Full Text] [Related]

  • 2. Safety and efficacy of combined ezetimibe/simvastatin treatment and simvastatin monotherapy in patients with non-alcoholic fatty liver disease.
    Abel T, Fehér J, Dinya E, Eldin MG, Kovács A.
    Med Sci Monit; 2009 Dec; 15(12):MS6-11. PubMed ID: 19946244
    [Abstract] [Full Text] [Related]

  • 3. [Effectiveness of ezetimibe in improving lipid goal attainment in patients with coronary heart diseases treated with statin].
    Cheng SJ, Yan HB, Ma Q, Xu FX.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Jun; 30(6):631-2. PubMed ID: 19957635
    [Abstract] [Full Text] [Related]

  • 4. A multicenter, randomized, double-blind, placebo-controlled, factorial design study to evaluate the lipid-altering efficacy and safety profile of the ezetimibe/simvastatin tablet compared with ezetimibe and simvastatin monotherapy in patients with primary hypercholesterolemia.
    Bays HE, Ose L, Fraser N, Tribble DL, Quinto K, Reyes R, Johnson-Levonas AO, Sapre A, Donahue SR, Ezetimibe Study Group.
    Clin Ther; 2004 Nov; 26(11):1758-73. PubMed ID: 15639688
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of ezetimibe and low-dose simvastatin as primary treatment for dyslipidemia in peritoneal dialysis patients.
    Suzuki H, Inoue T, Watanabe Y, Kikuta T, Sato T, Tsuda M.
    Adv Perit Dial; 2010 Nov; 26():53-7. PubMed ID: 21348380
    [Abstract] [Full Text] [Related]

  • 6. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis.
    Rossebø AB, Pedersen TR, Boman K, Brudi P, Chambers JB, Egstrup K, Gerdts E, Gohlke-Bärwolf C, Holme I, Kesäniemi YA, Malbecq W, Nienaber CA, Ray S, Skjaerpe T, Wachtell K, Willenheimer R, SEAS Investigators.
    N Engl J Med; 2008 Sep 25; 359(13):1343-56. PubMed ID: 18765433
    [Abstract] [Full Text] [Related]

  • 7. Comparison of the lipid-modifying efficacy and safety profiles of ezetimibe coadministered with simvastatin in older versus younger patients with primary hypercholesterolemia: a post Hoc analysis of subpopulations from three pooled clinical trials.
    Feldman T, Davidson M, Shah A, Maccubbin D, Meehan A, Zakson M, Tribble D, Veltri E, Mitchel Y.
    Clin Ther; 2006 Jun 25; 28(6):849-59. PubMed ID: 16860168
    [Abstract] [Full Text] [Related]

  • 8. Long-term safety and, tolerability profiles and lipid-modifying efficacy of ezetimibe coadministered with ongoing simvastatin treatment: a multicenter, randomized, double-blind, placebo-controlled, 48-week extension study.
    Masana L, Mata P, Gagné C, Sirah W, Cho M, Johnson-Levonas AO, Meehan A, Troxell JK, Gumbiner B, Ezetimibe Study Group.
    Clin Ther; 2005 Feb 25; 27(2):174-84. PubMed ID: 15811480
    [Abstract] [Full Text] [Related]

  • 9. [Muscular exertion--"embarrassment" in the evaluation of aminotransferases and creatine kinase serum levels].
    Drnek I, Rejmanová J, Skvor J.
    Cesk Pediatr; 1993 Jul 25; 48(7):417-8. PubMed ID: 8374980
    [Abstract] [Full Text] [Related]

  • 10. The efficacy and safety of fluvastatin in hypercholesterolemia in renal transplant recipients.
    Ghods AJ, Milanian I, Arghani H, Ghadiri G.
    Transplant Proc; 1995 Oct 25; 27(5):2579-80. PubMed ID: 7482835
    [No Abstract] [Full Text] [Related]

  • 11. Drug-induced liver injury associated with ezetimibe therapy.
    Liu Q, Tobias H, Petrovic LM.
    Dig Dis Sci; 2007 Feb 25; 52(2):602-5. PubMed ID: 17219067
    [No Abstract] [Full Text] [Related]

  • 12. Safety and efficacy of ezetimibe in a sample of cardiac transplant patients.
    Guisado Rasco A, Lage Gallé E, Sobrino Márquez JM, Sánchez Brotons JA, Mogollón Jiménez MV, Borrego Domínguez JM, Martínez Martínez A.
    Transplant Proc; 2008 Nov 25; 40(9):3058-9. PubMed ID: 19010193
    [Abstract] [Full Text] [Related]

  • 13. Ezetimibe in the treatment of uncontrolled hyperlipidemia in kidney transplant patients.
    Rodríguez-Ferrero ML, Anaya F.
    Transplant Proc; 2008 Dec 25; 40(10):3492-5. PubMed ID: 19100421
    [Abstract] [Full Text] [Related]

  • 14. [Effect of electric cardioversion on the activity of creatine kinase and its cardiac fraction and aspartate and alanine aminotransferases in the blood serum].
    Kolber-Postepska B, Markiewicz M, Miturzyńska-Stryjecka H, Horubała-Bielak G, Przegaliński J.
    Pol Tyg Lek; 1980 Nov 10; 35(45):1717-20. PubMed ID: 7220370
    [No Abstract] [Full Text] [Related]

  • 15. Efficacy of ezetimibe in patients with statin-resistant and statin-intolerant familial hyperlipidaemias.
    Wierzbicki AS, Doherty E, Lumb PJ, Chik G, Crook MA.
    Curr Med Res Opin; 2005 Mar 10; 21(3):333-8. PubMed ID: 15811200
    [Abstract] [Full Text] [Related]

  • 16. Safety and efficacy of long-term co-administration of fenofibrate and ezetimibe in patients with mixed hyperlipidemia.
    McKenney JM, Farnier M, Lo KW, Bays HE, Perevozkaya I, Carlson G, Davies MJ, Mitchel YB, Gumbiner B.
    J Am Coll Cardiol; 2006 Apr 18; 47(8):1584-7. PubMed ID: 16630994
    [Abstract] [Full Text] [Related]

  • 17. Treatment of familial hypercholesterolemia in children and adolescents: effect of lovastatin. Canadian Lovastatin in Children Study Group.
    Lambert M, Lupien PJ, Gagné C, Lévy E, Blaichman S, Langlois S, Hayden M, Rose V, Clarke JT, Wolfe BM, Clarson C, Parsons H, Stephure DK, Potvin D, Lambert J.
    Pediatrics; 1996 May 18; 97(5):619-28. PubMed ID: 8628597
    [Abstract] [Full Text] [Related]

  • 18. Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: efficacy and safety of ezetimibe co-administered with atorvastatin.
    Stein E, Stender S, Mata P, Sager P, Ponsonnet D, Melani L, Lipka L, Suresh R, Maccubbin D, Veltri E, Ezetimibe Study Group.
    Am Heart J; 2004 Sep 18; 148(3):447-55. PubMed ID: 15389231
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of the efficacy, safety, and tolerability of ezetimibe in primary hypercholesterolaemia: a pooled analysis from two controlled phase III clinical studies.
    Knopp RH, Dujovne CA, Le Beaut A, Lipka LJ, Suresh R, Veltri EP, Ezetimbe Study Group.
    Int J Clin Pract; 2003 Jun 18; 57(5):363-8. PubMed ID: 12846338
    [Abstract] [Full Text] [Related]

  • 20. Treatment of hypercholesterolemia with ezetimibe in cardiac transplant recipients.
    Patel AR, Ambrose MS, Duffy GA, Cote H, DeNofrio D.
    J Heart Lung Transplant; 2007 Mar 18; 26(3):281-4. PubMed ID: 17346631
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.